People · Operator

Mitchell Massey

Named in public records as an officer, director or promoter · active 2022–2024 · Biotech / Pharma, Other, Restaurants

3
Companies
3
Filings
$70.8M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
NOLA PharmaHoldings, LLCBiotech / PharmaSeries C$48.1M$448.1M2024
Missouri Vertical Investments LLCOtherSeries A$18.1M$27.0M2024
7B TX Holdings, LLCRestaurantsSeries A$4.5M$11.7M2022
Operator network

Mitchell Massey at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Peyton Bush · 5 companies · 1 sharedPeyton BushTerry Fitch · 2 companies · 1 sharedTerry FitchTodd Denton · 2 companies · 1 sharedTodd DentonReid Dove · 10 companies · 2 sharedReid DoveAlex Gray · 9 companies · 2 sharedAlex GrayStephen L. LaFrance, Jr. · 6 companies · 1 sharedStephen L. LaFran…Reid L. Dove · 5 companies · 1 sharedReid L. DoveRay Boyer · 2 companies · 1 sharedRay BoyerMitchell L. Massey · 1 companies · 1 sharedMitchell L. MasseyStephen LaFrance, Jr. · 1 companies · 1 sharedStephen LaFrance,…Luke Terrell · 4 companies · 1 sharedLuke TerrellNOLA PharmaHoldings, LLC · $48.1M raisedNOLA PharmaHoldings, …Missouri Vertical Investments LLC · $18.1M raisedMissouri Vertical Inv…7B TX Holdings, LLC · $4.5M raised7B TX Holdings, LLCMitchell MasseyMM
Mitchell Massey Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Mitchell Massey on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Reid Dove210
Alex Gray29
Stephen L. LaFrance, Jr.16
Peyton Bush15
Reid L. Dove15
Luke Terrell14
Ray Boyer12
Todd Denton12
Terry Fitch12
Stephen LaFrance, Jr.11
Mitchell L. Massey11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.